市場調査レポート
商品コード
1071936

リキッドバイオプシーの世界市場(2022年~2026年)

Global Fluid Biopsy Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.89円
リキッドバイオプシーの世界市場(2022年~2026年)
出版日: 2022年04月21日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のリキッドバイオプシーの市場規模は、2022年~2026年の間に17億4,000万米ドルの増加が見込まれ、予測期間中に18.77%のCAGRで成長が予測されています。

当レポートでは、世界のリキッドバイオプシー市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題のほか、約25社のベンダーを対象としたベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模(2021年)
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバル関係の脅威
  • 市況

第5章 市場セグメンテーション:技術別

  • 市場セグメント
  • 技術別の比較
  • CTC・ctDNA:市場規模と予測(2021年~2026年)
  • エクソソーム・RNA:市場規模と予測(2021年~2026年)
  • 技術別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別の情勢

  • 地域別のセグメンテーション
  • 地域別の比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • 英国:市場規模と予測(2021年~2026年)
  • フランス:市場規模と予測(2021年~2026年)
  • 地域別の市場機会

第8章 促進要因・課題・動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Bio Rad Laboratories Inc.
  • F. Hoffmann La Roche Ltd.
  • GeneFirst Ltd.
  • Guardant Health Inc.
  • HanaBioMed Life Sciences Ltd.
  • Illumina Inc.
  • MDxHealth Group
  • QIAGEN NV
  • Rarecells Inc.
  • Siemens Healthcare GmbH

第11章 付録

目次
Product Code: IRTNTR45000

Global Liquid Biopsy Market 2022-2026

Technavio has been monitoring the liquid biopsy market and it is poised to grow by $ 1.74 bn during 2022-2026, accelerating at a CAGR of 18.77% during the forecast period. Our report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer, growing focus on personalized medicine for cancer care, and increasing focus on early detection of cancer.

The liquid biopsy market analysis includes the technology segment and geographic landscape.

Technavio's liquid biopsy market is segmented as below:

By Technology

  • CTC and ctDNA
  • exosome and RNA

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing funding/investment for fluid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships and M&A and emerging applications of fluid biopsy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on liquid biopsy market covers the following areas:

  • Liquid biopsy market sizing
  • Liquid biopsy market forecast
  • Liquid biopsy market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include AccuraGen Holdings, Adaptive Biotechnologies Corp., ANGLE Plc, Bio Rad Laboratories Inc., Biocept Inc., CellMax Inc., Epigenomics AG, F. Hoffmann La Roche Ltd., GeneFirst Ltd., Guardant Health Inc., HansaBioMed Life Sciences Ltd., Illumina Inc., MDNA Lfe Sciences Inc., MDxHealth Group, NeoGenomics Laboratories Inc., QIAGEN NV, Rarecells Inc., SAGA Diagnostics AB, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Technology

  • 5.1 Market segments
  • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
  • 5.2 Comparison by Technology
  • Exhibit 26: Chart on Comparison by Technology
  • Exhibit 27: Data Table on Comparison by Technology
  • 5.3 CTC and ctDNA - Market size and forecast 2021-2026
  • Exhibit 28: Chart on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
  • 5.4 Exosome and RNA - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Exosome and RNA - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Exosome and RNA - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Technology
  • Exhibit 36: Market opportunity by Technology ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
  • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 France - Market size and forecast 2021-2026
  • Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity by geography
  • Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Bio Rad Laboratories Inc.
  • Exhibit 85: Bio Rad Laboratories Inc. - Overview
  • Exhibit 86: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 87: Bio Rad Laboratories Inc. - Key news
  • Exhibit 88: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 89: Bio Rad Laboratories Inc. - Segment focus
  • 10.4 F. Hoffmann La Roche Ltd.
  • Exhibit 90: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 91: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 92: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 93: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 94: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.5 GeneFirst Ltd.
  • Exhibit 95: GeneFirst Ltd. - Overview
  • Exhibit 96: GeneFirst Ltd. - Product / Service
  • Exhibit 97: GeneFirst Ltd. - Key offerings
  • 10.6 Guardant Health Inc.
  • Exhibit 98: Guardant Health Inc. - Overview
  • Exhibit 99: Guardant Health Inc. - Product / Service
  • Exhibit 100: Guardant Health Inc. - Key news
  • Exhibit 101: Guardant Health Inc. - Key offerings
  • 10.7 HansaBioMed Life Sciences Ltd.
  • Exhibit 102: HansaBioMed Life Sciences Ltd. - Overview
  • Exhibit 103: HansaBioMed Life Sciences Ltd. - Product / Service
  • Exhibit 104: HansaBioMed Life Sciences Ltd. - Key offerings
  • 10.8 Illumina Inc.
  • Exhibit 105: Illumina Inc. - Overview
  • Exhibit 106: Illumina Inc. - Business segments
  • Exhibit 107: Illumina Inc. - Key news
  • Exhibit 108: Illumina Inc. - Key offerings
  • Exhibit 109: Illumina Inc. - Segment focus
  • 10.9 MDxHealth Group
  • Exhibit 110: MDxHealth Group - Overview
  • Exhibit 111: MDxHealth Group - Business segments
  • Exhibit 112: MDxHealth Group - Key offerings
  • Exhibit 113: MDxHealth Group - Segment focus
  • 10.10 QIAGEN NV
  • Exhibit 114: QIAGEN NV - Overview
  • Exhibit 115: QIAGEN NV - Product / Service
  • Exhibit 116: QIAGEN NV - Key news
  • Exhibit 117: QIAGEN NV - Key offerings
  • 10.11 Rarecells Inc.
  • Exhibit 118: Rarecells Inc. - Overview
  • Exhibit 119: Rarecells Inc. - Product / Service
  • Exhibit 120: Rarecells Inc. - Key offerings
  • 10.12 Siemens Healthcare GmbH
  • Exhibit 121: Siemens Healthcare GmbH - Overview
  • Exhibit 122: Siemens Healthcare GmbH - Business segments
  • Exhibit 123: Siemens Healthcare GmbH - Key news
  • Exhibit 124: Siemens Healthcare GmbH - Key offerings
  • Exhibit 125: Siemens Healthcare GmbH - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Technology - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Technology
  • Exhibits27: Data Table on Comparison by Technology
  • Exhibits28: Chart on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Exosome and RNA - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Exosome and RNA - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Technology ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share by geography 2021-2026 (%)
  • Exhibits39: Data Table on Market share by geography 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity by geography ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Bio Rad Laboratories Inc. - Overview
  • Exhibits86: Bio Rad Laboratories Inc. - Business segments
  • Exhibits87: Bio Rad Laboratories Inc. - Key news
  • Exhibits88: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits89: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits90: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits91: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits92: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits93: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits94: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits95: GeneFirst Ltd. - Overview
  • Exhibits96: GeneFirst Ltd. - Product / Service
  • Exhibits97: GeneFirst Ltd. - Key offerings
  • Exhibits98: Guardant Health Inc. - Overview
  • Exhibits99: Guardant Health Inc. - Product / Service
  • Exhibits100: Guardant Health Inc. - Key news
  • Exhibits101: Guardant Health Inc. - Key offerings
  • Exhibits102: HansaBioMed Life Sciences Ltd. - Overview
  • Exhibits103: HansaBioMed Life Sciences Ltd. - Product / Service
  • Exhibits104: HansaBioMed Life Sciences Ltd. - Key offerings
  • Exhibits105: Illumina Inc. - Overview
  • Exhibits106: Illumina Inc. - Business segments
  • Exhibits107: Illumina Inc. - Key news
  • Exhibits108: Illumina Inc. - Key offerings
  • Exhibits109: Illumina Inc. - Segment focus
  • Exhibits110: MDxHealth Group - Overview
  • Exhibits111: MDxHealth Group - Business segments
  • Exhibits112: MDxHealth Group - Key offerings
  • Exhibits113: MDxHealth Group - Segment focus
  • Exhibits114: QIAGEN NV - Overview
  • Exhibits115: QIAGEN NV - Product / Service
  • Exhibits116: QIAGEN NV - Key news
  • Exhibits117: QIAGEN NV - Key offerings
  • Exhibits118: Rarecells Inc. - Overview
  • Exhibits119: Rarecells Inc. - Product / Service
  • Exhibits120: Rarecells Inc. - Key offerings
  • Exhibits121: Siemens Healthcare GmbH - Overview
  • Exhibits122: Siemens Healthcare GmbH - Business segments
  • Exhibits123: Siemens Healthcare GmbH - Key news
  • Exhibits124: Siemens Healthcare GmbH - Key offerings
  • Exhibits125: Siemens Healthcare GmbH - Segment focus
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations